CDC (CDC) Institutional Ownership
None of the superinvestors we track currently report CDC in their latest SEC Form 13F filings.
13F filings cover institutional equity holdings and are reported quarterly with a delay. This stock may still have insider Form 4 activity or appear in future filings.
When tracked funds report positions in CDC, this page will show 13F-reported ownership trends, hedge fund exposure, portfolio concentration, historical 13F filings, and estimated holding performance.
Institutional Ownership Trend
| Portfolio quarter | Institutional holders | Total reported value | Total shares |
|---|---|---|---|
| Q4 2023 | 1 | $2,659 | 47,000 |
| Q2 2023 | 1 | $1,319 | 22,900 |
| Q4 2022 | 1 | $360 | 5,800 |
| Q1 2022 | 1 | $2,982 | 41,500 |
| Q4 2021 | 1 | $988 | 14,200 |
| Q3 2021 | 1 | $399 | 6,200 |
Related CDC Institutional Insights:
- CDC Institutional Ownership & Insiders Activity
- CDC Institutional Ownership & 13F Activity
- CDC Top Institutional Shareholders
- CDC Institutional Buying Activity
- CDC Institutional Selling Activity
- Institutional Portfolio Overlap & Shared Holdings
- CDC Insider Trading & SEC Form 4 Activity
- Top Institutional Investor Stock Rankings